CytoDyn Inc. Quarterly Costs and Expenses in USD from Q1 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
CytoDyn Inc. quarterly/annual Costs and Expenses history and growth rate from Q1 2020 to Q3 2024.
  • CytoDyn Inc. Costs and Expenses for the quarter ending August 31, 2024 was -$22.4M, a 586% decline year-over-year.
  • CytoDyn Inc. Costs and Expenses for the twelve months ending August 31, 2024 was -$8.99M, a 125% decline year-over-year.
  • CytoDyn Inc. annual Costs and Expenses for 2023 was $18.1M, a 55.5% decline from 2022.
  • CytoDyn Inc. annual Costs and Expenses for 2022 was $40.6M, a 72.1% decline from 2021.
  • CytoDyn Inc. annual Costs and Expenses for 2021 was $146M, a 39.2% increase from 2020.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$8.99M -$22.4M -$27M -586% Jun 1, 2024 Aug 31, 2024 10-Q 2024-10-15
Q2 2024 $18.1M $6.63M +$2.85M +75.5% Mar 1, 2024 May 31, 2024 10-K 2024-08-15
Q1 2024 $15.2M $3.41M -$507K -12.9% Dec 1, 2023 Feb 29, 2024 10-Q 2024-04-15
Q4 2023 $15.7M $3.4M -$19.8M -85.3% Sep 1, 2023 Nov 30, 2023 10-Q 2024-01-16
Q3 2023 $35.5M $4.61M -$5.1M -52.5% Jun 1, 2023 Aug 31, 2023 10-Q 2024-10-15
Q2 2023 $40.6M $3.78M -$75.3M -95.2% Mar 1, 2023 May 31, 2023 10-K 2024-08-15
Q1 2023 $116M $3.92M -$15.5M -79.8% Dec 1, 2022 Feb 28, 2023 10-Q 2024-04-15
Q4 2022 $131M $23.2M -$2.33M -9.15% Sep 1, 2022 Nov 30, 2022 10-Q 2024-01-16
Q3 2022 $134M $9.71M -$12M -55.2% Jun 1, 2022 Aug 31, 2022 10-Q 2023-10-23
Q2 2022 $146M $79M +$55.3M +233% Mar 1, 2022 May 31, 2022 10-K 2023-09-14
Q1 2022 $90.3M $19.4M -$11.4M -37% Dec 1, 2021 Feb 28, 2022 10-Q 2023-04-10
Q4 2021 $102M $25.5M +$992K +4.05% Sep 1, 2021 Nov 30, 2021 10-Q 2023-01-09
Q3 2021 $101M $21.7M -$3.89M -15.2% Jun 1, 2021 Aug 31, 2021 10-Q/A 2022-10-13
Q2 2021 $105M $23.7M Mar 1, 2021 May 31, 2021 10-K 2022-08-15
Q1 2021 $30.8M +$8.71M +39.5% Dec 1, 2020 Feb 28, 2021 10-Q 2022-04-11
Q4 2020 $24.5M Sep 1, 2020 Nov 30, 2020 10-Q 2022-01-10
Q3 2020 $25.6M Jun 1, 2020 Aug 31, 2020 10-Q 2021-10-12
Q1 2020 $22.1M Dec 1, 2019 Feb 29, 2020 10-Q 2021-04-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.